Skip to main content

Health economic modeling for medical technologies in Europe

Early and comprehensive economic models to determine economic value proposition and inform healthcare decision-makers

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

AGENAS calls for submissions of medical devices for evaluation within National HTA Program

06 Mar 2023

National HTA Program for Medical Devices was published in September 2017. Despite the fact that it was possible to suggest technologies for evaluation, there was no information on the actual work being done or the outcomes/consequences of the assessments within this program.

On February 17, 2023, the National Agency for Regional Health Services (AGENAS) invited applicants to submit proposals for the evaluation of medical technologies within the National HTA Program for Medical Devices (PNHTADM).

Proposals can be made concerning both emerging technologies, i.e., technologies that do not yet have the CE marking, and those in the initial diffusion phase, commonly used or presumed obsolete devices, for the possible evaluation or re-evaluation of the appropriate use in the Italian National Health Service (NHS). Applicants can be regions, hospitals, NHS professionals, scientific societies, manufacturers and their associations, and citizens/patients and their associations.

The submissions can be made through the AGENAS webpage. The AGENAS’ HTA Operational Unit will analyze the submitted proposals to be submitted to the Steering Committee of Medical Devices within the Ministry of Health for the subsequent evaluation phase within the PNHTADM. See the full details here

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.